4/A: Clifford Sosin of CAS Investment Partners Amends Form 4 After Cardlytics Transactions
SEC Filing (Form 4/A)
Clifford Sosin, Managing Member of CAS Investment Partners, amends his Form 4 filing to report transactions in Cardlytics, Inc. stock and convertible notes, and agrees to disgorge profits from these transactions.
Summary
- Clifford Sosin, as Managing Member of CAS Investment Partners, filed an amended Form 4 to report transactions in Cardlytics, Inc. (CDLX) securities.
- The transactions include purchases of common stock on May 9, 2024, May 10, 2024, and May 13, 2024, at prices of $8.7275, $8.7854, and $8.986 per share, respectively.
- Sosin Master, L.P. and CSWR Partners, L.P. directly hold the common stock and convertible notes, with Sosin potentially deemed the beneficial owner due to his role at CAS.
- Sosin Master holds $16,498,366 and CSWR holds $7,501,634 principal amount of Cardlytics' 4.25% Convertible Senior Notes due 2029.
- The notes are convertible into common stock at a rate of 55.4939 shares per $1,000 principal amount.
- Sosin has agreed to voluntarily disgorge any statutory profits resulting from these transactions.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While there's an amended filing and agreement to disgorge profits, it doesn't necessarily indicate a major negative event, but rather a correction of previous reporting. The purchases themselves could be seen as a positive sign of confidence, but the need for amendment tempers this.
Positives
- Clifford Sosin's agreement to disgorge profits could be seen as a positive step towards regulatory compliance and investor confidence.
Negatives
- The amended filing and agreement to disgorge profits suggest potential issues with the initial reporting or transactions.
Risks
- The need for an amended filing and the agreement to disgorge profits could raise concerns about internal controls or compliance procedures at CAS Investment Partners.
- The transactions could attract further scrutiny from regulatory bodies.
Industry Context
Form 4 filings are standard practice for reporting transactions by company insiders and large shareholders, providing transparency to the market.
Comparison to Industry Standards
- Form 4 filings are a common regulatory requirement for individuals and entities deemed insiders, such as officers, directors, and beneficial owners holding more than 10% of a company's stock, as well as those with access to non-public information.
- The SEC requires these filings to ensure transparency and prevent insider trading, allowing investors to monitor the trading activities of those with privileged information.
- The disgorgement of profits, as agreed to by Clifford Sosin, is a remedy often pursued by the SEC in cases of potential violations of Section 16(b) of the Securities Exchange Act of 1934, which aims to prevent short-swing profits by insiders.
Stakeholder Impact
- The amended filing and agreement to disgorge profits could impact shareholder confidence, potentially leading to increased scrutiny of insider transactions.
- The transactions themselves could influence the stock price, depending on market perception of the insider's actions.
Key Dates
| Date | Description |
|---|---|
| 05/09/2024 | Purchase of 225,000 shares of Common Stock at $8.7275 |
| 05/10/2024 | Purchase of 100,000 shares of Common Stock at $8.7854 |
| 05/13/2024 | Original Form 4 filed |
| 05/13/2024 | Purchase of 3,746 shares of Common Stock at $8.986 |
| 05/14/2024 | Date of amended filing (Form 4/A) |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.